Friday March 19 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

BioNews - BioPortfolio's News Portal
Biotechnology Equity prices/deals News and Headlines

Sign-up to BioPortfolio's
Biotechnology Equity Prices news alerts.
Subscribe to
Share price RSS feed - - View full RSS Index
Subscribe to BioWatch News Email alerts - open BioWatch PDF brochure.
Publish your news using BioNewsCast - open BioNewsCast PDF brochure.

Aventis Pharma in good health
Moneycontrol.com:  similar ...
Capital Valmoris Inc. ("Valmoris"), Biotonix Inc. ("Biotonix") and Sylvain Guimond ("Guimond") Announce the Closing of Their Qualifying Transaction an
Yahoo! Canada:  similar ...
Tuesday`s Top Percentage Stock Movers (LXRX, SQNM, ADY, UWBK)
Earthtimes.org:  similar ...
Lexicon shares down on stock sale
Business Journal of Jacksonville:  similar ...
Genomic Health Inc. (GHDX) COO & CFO G Bradley Cole sells 2,500 Shares
Guru Focus:  similar ...
WebMD Health increases pricing of tender offer for common stock to $46.80 per share
News-Medical.Net:  similar ...
Ablynx Intends to Raise up to EUR57.5 Million with Secondary Public Offering - Price Range: EUR7.20 - EUR7.75
BioPortfolio:  similar ...
Lexicon Prices Offering
About:  similar ...
Harley-Davidson Rumored To Be Acquisition Target
About:  similar ...
Meridian Bioscience Inc. (VIVO) CEO John A Kraeutler sells 19,608 Shares
Guru Focus:  similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
MedIndia:  similar ...
BUYINS.NET: (VPHM) SqueezeTrigger Price is $13.232. There is $67,...
Zibb:  similar ...
BUYINS.NET: (VPHM) SqueezeTrigger Price is $13.232. There is $67,118,487.00 That Short Sellers Still Need To Cover
TradingMarkets:  similar ...
Ablynx Successfully Raises Eur50 Million With Secondary Public Offering - Final Price: Eur7.5 Per Share
NewsBlaze:  similar ...
Ablynx Successfully Raises Eur50 Million With Secondary Public Offering - Final Price: Eur7.5 Per Share
Pharmacy Choice:  similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Boston Business Journal:  similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Yahoo! Canada:  similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
St Louis Business Journal:  similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Dallas Business Chronicle:  similar ...
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
Memphis Business Journal:  similar ...

Search BioNews

      ---Advanced searching---

Sign-up to BioPortfolio's Biotechnology Equity Prices news alerts.
Subscribe to BioWatch News Email alerts - open BioWatch PDF brochure.
Publish your news using BioNewsCast - open BioNewsCast PDF brochure.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.